沙丁胺醇人工抗原的合成及抗体制备

沙丁胺醇是一种β-兴奋剂,常被很多畜禽水产养殖户非法用于动物养殖。为建立沙丁胺醇在食品中残留的快速检测方法,研究了沙丁胺醇免疫原的合成和抗体的制备方法。采用对氨基苯甲酸法合成了沙丁胺醇（SAL）免疫原SAL-cBSA,采用重氮化法合成的克伦特罗（CL）偶合物CL-cOVA作为包被抗原,用紫外光谱法分析了所合成免疫原和包被抗原。用免疫原SAL-cBSA免疫新西兰大白兔获得多克隆抗体,抗体效价达到32000。采用间接ELISA法检测抗体IC50值为8.79ng/ml,SAL的浓度在1ng/ml~100ng/ml区间时,SAL与对抗体的竞争结合力呈直线关系。表明所制备的沙丁胺醇免疫原具有良好的免疫原性,所制备的抗体拥有很高的灵敏度。     

双交联法制备桔霉素-蛋白质偶联抗原及抗体

以1,4-丁二醇二缩水甘油醚(双环氧试剂)为偶联剂,合成桔霉素-蛋白质偶联抗原CIT-BSA,经过HPLC分析、紫外扫描和红外光谱鉴定表明,偶联物成功制备,CIT/BSA的偶联比为8.16.通过免疫BALB/C小鼠,获得抗桔霉素多克隆抗体,经间接ELISA检测,效价达到1.1×105.间接竞争ELISA表明,桔霉素(CIT)的最低检测浓度为10μg/L,其线性范围为10～250μg/L,IC50为100μg/L.分析了不同方法制备的偶联抗原的免疫原性,实验表明,桔霉素抗原决定簇C7位置的羧基保留是获得针对桔霉素特异性抗体的必要条件.为快速检测桔霉素的酶联免疫检测技术的建立和检测试剂盒的研制提供技术依据.     

脱落酸人工抗原合成及多克隆抗体制备

目的:为了对植物细胞中的脱落酸(ABA)进行定量和定位分析,研究了脱落酸人工抗原的合成以及多克隆抗体的制备。方法:用重氮化法将ABA分别与牛血清白蛋白(BSA)、卵清白蛋白(OVA)联结,得到ABA的免疫抗原和包被抗原,并采用紫外全波长扫描和SDS-PAGE对合成的抗原进行了鉴定。以经过鉴定的抗原免疫白兔,制备出ABA的多克隆抗体;采用间接酶联免疫法(ELISA)对抗血清进行效价检测,通过离子交换层析法获得纯化的抗体。结果:ABA与BSA的平均偶联比为5.3∶1,抗血清效价为1∶16000。结论:人工抗原和多克隆抗体制备成功,为采用ELISA和免疫胶体金技术(ICG)检测ABA提供了有效工具。     

乙型肝炎表面抗原单克隆抗体的制备及其应用

目的：研制能够同时检测乙型肝炎表面抗原(HBsAg) 野生株和多种变异株的单克隆抗体（mAb）,将筛选出的mAb进行纯度、免疫学性状鉴定,并对其应用效果及质量做初步评价。方法：用中国乙型肝炎病毒感染者血清中分离的HBsAg免疫小鼠,利用杂交瘤细胞融合技术制备抗HBsAg野生株和多种变异株的mAb,将筛选出的mAb经饱和硫酸铵纯化后通过聚丙烯酰胺凝胶电泳、琼脂糖凝胶电泳、ELISA鉴定其纯度、特性,初步评价其应用效果及质量。结果：获得了一株能够同时检测HBsAg野生株和多种变异株的mAb,命名为D12。其纯度较高,特异性强,灵敏度好,Ig亚类测定结果为IgG1,识别位点存在于自然抗原上,其检测HBsAg野生株的能力优于现行3种国产试剂盒,检测HBsAg变异株的能力明显优于现行5种国产试剂盒。结论：成功研制了可以同时识别HBsAg野生株和大多数变异株的mAb,为进一步提高我国当前乙型肝炎病毒变异株的检出率以及加强预防和控制乙型肝炎病毒的传播奠定新的基础。     

Preparation and Characterisation of a Monoclonal Antibody to an Antigen Enriched in Chick Brain Postsynaptic Densities

Abstract: The preparation and characterisation of a monoclonal antibody to an antigen enriched in day-old chick brain postsynaptic densities (PSDs), with respect to other subcellular loci, are described. Immunolabelling with this antibody produced a dendritic immunoprecipitate that was markedly stronger in PSDs than in other subcellular loci. Thus, the antiserum could be used as a marker for PSDs during their purification by subcellular fractionation, as well as in the study of PSD assembly. Monoclonal antibody 411B has already been shown to be a useful tool in the chemical determination of changes in synapse density after various experimental manipulations in both the chick and rat. In the present study, we have used the antiserum to monitor the appearance and maintenance or redundancy of synaptic components in the developing chick forebrain.     

制备肺炎衣原体抗原片检测血清抗体

目的:探索肺炎衣原体抗原片检测血清抗体法在诊断Cpn感染中的实际应用前景。方法:应用进口肺炎衣原体(Cpn)毒株感染Hep-2细胞,分别以瑞氏-姬母萨染色、吖啶橙染色和直接免疫荧光染色等3种方法鉴定Cpn感染细胞。纯化获取大量Cpn抗原,用于制备斑点抗原片。建立微量免疫荧光染色法(MIF)检测血清抗体,诊断Cpn感染。结果:Cpn感染Hep-2细胞的最适条件是用含1μg/mL放线菌酮的维持液,在35℃、5%CO2孵箱中培养7d,并在培养的第0、3、4、5天以2600r/min离心1h,感染成功率极高。染色反应显示,瑞氏-姬母萨染色可将Cpn包涵体染成蓝紫色或红紫色;吖啶橙染色则使Cpn感染的Hep-2细胞呈现鲜明的橘红色;免疫荧光抗体染色后,在Cpn感染细胞内可见亮苹果绿色包涵体。通过斑点抗原荧光抗体染色的方法抽样检测了100份病人血清中的Cpn抗体,其中抗Cpn-IgG抗体的阳性血清共61份,阳性率为61%。与Cpn-外周血单核细胞(Cpn-PBMC)抗原片比较,阳性检出率无明显差别。结论:用Cpn感染细胞制作的Cpn斑点抗原片可用于临床检测血清Cpn-IgG抗体,且具有特异性、敏感性高的特点,但要求检测人员有一定的经验。     

Preparation of Australia Antigen Free Human Albumin with Polyethylene Glycol

Albumin was prepared from human plasma diluted In 0.05M phosphate buffer pH 8.6, by the precipitation of approximately 95% of the associated plasma proteins with 357. polyethylene glycol. More than 70% of the albumin In the original plasma was recoverable as a viscous liquid on lowering the pH to 5.5. The albumin prepared by this technique is associated with 5 to 10% or and B globulin. Plasma, positive for Australia antigen (Au(SH)ag) yields an albumin preparation negative for the antigen.     

Total Screening of Blood Donations for Australia (Hepatitis Associated) Antigen and its Antibody

During a period of one year all of 105,724 blood donations were tested for Australia (Au) antigen and its antibody by rapid immunoelectro-osmophoresis—86 (1 in 1,229) were positive for antigen and 67 (1 in 1,578) positive for antibody. Second donations by previously negative donors reduce the overall incidence of positives. Men prisoners have a significantly higher incidence of Au antigen (1 in 153) than non-institutionalized men (1 in 803). The latter have a significantly higher incidence of antigen than women (1 in 2,019). Only one antigen-positive donor was incubating acute viral hepatitis. Failure to detect one strong and one weak antigen was responsible for two cases of posttransfusion Au-antigen-positive hepatitis.     

Effect of Histoplasmosis on Antibody Response to an Erythrocyte Antigen

Infection of mice with Histoplasma capsulatum depressed their ability to form agglutinins against foreign erythrocytes. Animals previously inoculated with 10(8) yeast cells of H. capsulatum showed the most significant depression, occurring when erythrocytes were injected 8 days after infection. The average log(2) hemagglutinin titer was 2.7 compared to 8.0 for the control (noninfected) group. In general, depression of hemagglutinin response in all infected mice was greatest 8 days after infection, but response was back to near normal after 16 days and stayed at that level for the remaining time tested (24 days).     

小鼠黑色素瘤相关抗原MART1的原核表达及抗体制备

目的:利用基因重组技术获得鼠黑色素瘤相关抗原MART1,并制备兔抗鼠多克隆抗体。方法:采用RT-PCR方法从小鼠黑素瘤B16-F1细胞株总RNA中扩增MART1的编码c DNA序列,并构建p ET32a-MART1原核表达质粒,将此质粒转化大肠杆菌Rosseta(DE3)菌株后用IPTG诱导表达,获得的MART1融合蛋白依次用Ni-NTA亲和层析和制备性聚丙烯酰胺凝胶电泳分离纯化,纯化的MART1融合蛋白用SDS-PAGE和Western印迹鉴定;以纯化的MART1融合蛋白为抗原,皮内接种日本大耳白兔,制备多克隆抗体,采用ELISA、Western印迹和细胞免疫荧光法分别检测兔血清中抗体的效价及抗原的特异性。结果:构建出MART1原核表达质粒,小鼠MART1基因在大肠杆菌Rosseta(DE3)中可诱导性表达并有效纯化;用纯化的MART1蛋白在日本大耳白兔中制备出高效价的多克隆抗体(效价1∶1 024 000),该抗体可与原核及真核表达的MART1蛋白特异性结合。结论:建立了鼠MART1蛋白原核表达和纯化技术,制备出的高效价和特异性抗MART1多克隆抗体将为黑色素瘤的防治研究提供技术支撑。     

RNA of Australia Antigen

ALTHOUGH the exact nature of Australia (Au) antigen is not resolved, increasing evidence suggests that it is the causal agent of viral hepatitis. This supposition is based chiefly on the frequent occurrence of Au antigen in the sera of patients with viral hepatitis^1–4 and on its virus-like appearance under the electron microscope^5–7. Biochemical studies have shown that Au antigen consists largely of protein, with a minor lipid moiety^{8, 9}. So far, however, no genetic material has been detected in the Au antigen and it has been suggested that the Au antigen might be “a unique infectious particle with little or no nucleic acid”¹⁰. We wish to present evidence, however, that RNA is an essential component of Au antigen.     

Expression of HSV-1 ICPO Antigen Peptide in Prokaryotic Cells and Preparation of Specific Antibody

As an immediate-early protein of herpes simplex virus, infected-cell polypeptide 0 （ICP0） exhibits complicated interactions with host cells, and its regulatory function on gene expression is of great importance. Since the ICP0 encoding sequence contains many rare codons which are absent in E.coli, and ICP0 is highly unstable in prokaryotic cells, expression of entire ICP0 in prokaryotic cells has never been reported. In order to further investigate the function of ICP0, a recombinant plasmid was constructed by subcloning a cDNA fragment encoding an amino-terminal of 105 residues of the ICP0 protein into pGEX-5x-1 vector. The resulting GST-105 fusion antigen peptide was expressed with high efficiency in E.coli. Antibodies prepared after the immunization of mice with purified fusion protein can recognize not only the denatured ICPO protein, but also the native ICPO protein with normal biological conformation.     

土拉弗朗西斯菌两种不同长度的外膜蛋白FopA抗原和抗体的制备

目的:根据外膜蛋白 FopA 的序列信息,建立土拉弗朗西斯菌 FopA蛋白全长(FopA-L)和部分(FopA-S)的特异性抗原的 BL21 表达系统,获得高活性的重组 FopA-L、FopA-S蛋白并制备相应的多克隆抗体,为土拉菌的监测、诊断和治疗提供依据。方法:通过 pET100 质粒构建FopA-L及FopA-S的表达载体,转化大肠杆菌BL21细胞并诱导表达FopA-L及FopA-S蛋白,螯合镍离子次氨基三乙酸(Ni-NTA)亲合层析纯化FopA蛋白,用重组蛋白免疫大耳白兔制备多克隆抗体,通过 ELISA、Western 印迹、胶体金免疫层析技术等方法进行检测。结果:构建了FopA-L及FopA-S的表达载体,获得相应的高表达目的蛋白 BL21 细胞株,用表达的蛋白为抗原成功制备了 FopA特异性的抗体,效价皆在1 ∶100000以上且特异性良好。结论:FopA-S与FopA-L两种抗原和相应抗体的制备为建立土拉菌快速检测方法奠定了基础。     

New Specificity of Australia Antigen

THE immunodiffusion laboratory at the Institute for Cancer Research frequently acts as a reference laboratory to test anti-Australia antigen sera for our colleagues in many parts of the world. Because Australia antigen is known to possess different antigenic specificities^1–4, a panel was established which consisted of Australia antigen specimens selected from hepatitis and Down's syndrome patients and from clinically normal residents of the Lau area in Malaita, British Solomon Islands. Sera from normal blood donors without Australia antigen were included as negative controls. All antisera received after August 1971 were tested against this panel to detect heterogeneity among both the antibodies tested and the antigens included in the panel. Immunodiffusion was performed in a seven-hole Ouchterlony pattern with the antiserum in the centre well and a positive Australia antigen control serum from a Pennsylvania Down's syndrome patient in the top and bottom wells. The patterns were cut in a layer of 1.1% agarose in veronal buffer, pH 8.2, on glass lantern slides^6,7.     

Biophysical Properties of Australia Antigen

Biophysical studies with Australia complement-fixing (CF) antigen showed it to be a particle with a buoyant density of 1.20 g/cm(3) in CsCl, a sedimentation coefficient of 110, and an average diameter of 25 nm. The CF antigen was not inactivated by ether, 1% deoxycholate, 1% Tween 80 or overnight heating at 56 C. The antigen was unstable when treated with 1% sodium dodecyl sulfate. A procedure is described for the isolation and partial purification of Australia antigen from serum by using isopycnic banding and rate separation techniques. Treatment of the 1.20 g/cm(3) Australia antigen with 1% Tween 80 yielded a minor peak of CF activity with a buoyant density of 1.39 g/cm(3) in CsCl.     

Expression of HSV-1 ICP0 Antigen Peptide in Prokaryotic Cells and Preparation of Specific Antibody

As an immediate-early protein of herpes simplex virus, infected-cell polypeptide 0 (ICP0) exhibits complicated interactions with host cells, and its regulatory function on gene expression is of great importance. Since the ICP0 encoding sequence contains many rare codons which are absent in E.coli, and ICP0 is highly unstable in prokaryotic cells, expression of entire ICP0 in prokaryotic cells has never been reported. In order to further investigate the function of ICP0, a recombinant plasmid was constructed by subcloning a cDNA fragment encoding an amino-terminal of 105 residues of the ICP0 protein into pGEX-5x-1 vector. The resulting GST-105 fusion antigen peptide was expressed with high efficiency in E.coli. Antibodies prepared after the immunization of mice with purified fusion protein can recognize not only the denatured ICP0 protein, but also the native ICP0 protein with normal biological conformation.     

Natural Antibody in Mammalian Serum Reacting with an Antigen in Some Leptospires

Serum from normal mammals agglutinated and immobilized nonpathogenic Leptospira biflexa and agglutinated avirulent lines of pathogenic serotypes L. icterohaemorrhagiae and L. zanoni. Virulent lines of L. icterohaemorrhagiae and L. zanoni were not affected, nor were any of three strains of L. pomona, one of which was avirulent. The active principle in serum was a beta-macroglobulin which was heat-labile and reduced by 2-mercaptoethanol, and acted in conjunction with complement and lysozyme; it was absorbable from serum by Formalin-treated susceptible leptospires. The Formalin-stable receptor antigen, named "Z antigen," is associated with virulence rather than pathogenicity, but may not be a determinant of virulence.     

炭疽菌保护性抗原受体结合区的表达及其多克隆抗体的制备

原核表达炭疽杆菌保护性抗原受体结合区并制备该蛋白的多克隆抗体.从炭疽芽胞杆菌A16R中经PCR扩增得到了炭疽菌保护性抗原(PA)受体结合区基因,即PA的第四结构域(PA-D4),将其克隆至含有6×His编码序列的原核表达载体pET-2b(+)中,将重组质粒转化大肠杆菌BL21(DE3),在IPTG诱导下进行蛋白表达;用HiTrapTM Chelating HP柱纯化重组蛋白,Western blot进一步鉴定;以纯化后的蛋白为抗原,免疫新西兰大耳白兔制备该蛋白的多克隆抗体;用ELISA和Western blot检测抗血清.结果表明,目的蛋白在大肠杆菌BL21(DE3)中获得了可溶性表达,纯化后纯度可达90%以上;制备了针对PA-D4融合蛋白的高效价抗血清,ELISA抗体滴度为1∶ 102 400;其抗体能特异性识别内源性的PA.PA-D4重组蛋白及其多克隆抗体的获得,为后续研究其功能和炭疽疫苗免疫保护机制奠定了基础.     

The Identification of an Anther Specific Antigen inBrassicaSpecies using a Heterologous Monoclonal Antibody

Monoclonal antibody, MAb 69-139-19, raised against sheep sperm,cross-reacted with anther proteins from fourBrassicaspeciestested. Early in anther development the MAb weakly detecteda polypeptide of42 kDa. At the mid-maturation stage the MAbstill bound weakly to this band but it also detected a polydisperseband of Mr 160–230 kDa. In mature pollen MAb 69-139-19labelled the polydisperse region of 160–230 kDa very strongly,as well as a faint, but distinct, band of116 kDa. Immunogoldlabelling ofB. napusL. anthers and pollen grains also showeda differential pattern of labelling. At the early vacuolatestage the MAb recognized an antigen within the tapetum and themicrospore cytoplasm and nucleus. During the late vacuolatestage the MAb bound to the tapetal material during transferto the pollen grain wall, leading to strong labelling of thepollen wall at maturity. In sheep MAb 69-139-19 binds to thepostacrosomal region of the sperm (Hou, 1989). The polypeptidepresent in plants, which contains the epitope recognized bythe MAb is likely to be a different protein to that in sheep,but we suggest that it plays a role in sexual reproduction inBrassica.It is possible that as the polypeptide is located in the pollencoat it may be involved in pollen/stigma interactions duringpollination leading to successful adhesion and pollen tube germination. Brassica napusL; incongruity; pollen-stigma recognition; pollination; rapeseed; heterologous antibody     

Production of an Anti-Prostate-Specific Antigen Single-Chain Antibody Fragment from Pichia pastoris

Prostate-specific antigen (PSA) is a widely used marker for screening and monitoring prostate cancer. Because PSA levels are normally quite low, an antibody-based assay must be used to detect PSA. However, not all PSA-specific antibodies bind equally well to PSA or to its different isoforms. Therefore, a better understanding of how PSA interacts with PSA-specific antibodies is of considerable clinical interest. B80.3 is a widely used murine monoclonal anti-PSA antibody (IgG), which has very high affinity for both free and α-anti-chymotrypsin complexed PSA. More importantly, its gene sequence is known—making it one of only two anti-PSA antibodies that has been fully cloned and sequenced. To better elucidate the interaction between PSA and B80.3, a single-chain antibody fragment, derived from the variable domain of B80.3 (scFvB80), was cloned into a pPIC9 vector and expressed in Pichia pastoris. The secreted protein was purified using a three-step protocol beginning with a 50% ammonium sulfate precipitation step, followed by a T-gel thio-affinity step and concluding with a simple anion-exchange (DE52) filtration step. NMR studies indicate the protein is correctly folded while competitive enzyme-linked immunosorbant assays show that the purified scFvB80 has approximately 20% of the activity of the full-length B80.3 antibody. The protocol described here provides a quick and convenient route to prepare large quantities of very pure anti-PSA antibody fragments (15–20 mg/L culture medium) for detailed structural and biophysical characterization.